To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc.
Hoffmann-La Roche
Alume Biosciences, Inc.
TransThera Sciences (Nanjing), Inc.
Dana-Farber Cancer Institute
Genexine, Inc.